Targeting Overactive Mitochondrial Pathways Kills Aggressive Melanoma Cells Using Existing Drugs

Researchers have identified a vulnerability in aggressive melanoma cells, the deadliest form of skin cancer, by targeting mitochondrial pathways. The study found that these melanoma cells overactivate two critical processes within mitochondria, which are responsible for generating energy in cells. By blocking these pathways using existing drugs, including antibiotics and energy inhibitors, scientists effectively killed the melanoma cells.

The findings highlight the role of mitochondria in driving the aggressiveness of certain melanomas. Researchers observed that disrupting these overactive mitochondrial functions with readily available medications led to significant cell death in laboratory settings. This approach leverages existing pharmaceutical options to interfere with the energy production mechanisms that sustain aggressive cancer growth. The study provides insight into potential therapeutic strategies for treating advanced melanoma by focusing on cellular energy pathways.

Newsflash | Powered by GeneOnline AI

Source: GO-AI-ne1

Date: June 23, 2025

Author

Mark Chiang